» Articles » PMID: 15312213

Prevalence and Incidence of Severe Sepsis in Dutch Intensive Care Units

Overview
Journal Crit Care
Specialty Critical Care
Date 2004 Aug 18
PMID 15312213
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Severe sepsis is a dreaded consequence of infection and necessitates intensive care treatment. Severe sepsis has a profound impact on mortality and on hospital costs, but recent incidence data from The Netherlands are not available. The purpose of the present study was to determine the prevalence and incidence of severe sepsis occurring during the first 24 hours of admission in Dutch intensive care units (ICUs).

Methods: Forty-seven ICUs in The Netherlands participated in a point prevalence survey and included patients with infection at the time of ICU admission. Clinical symptoms of severe sepsis during the first 24 hours of each patient's ICU stay were recorded and the prevalence of severe sepsis was calculated. Then, the annual incidence of severe sepsis in The Netherlands was estimated, based on the prevalence, the estimated length of stay, and the capacity of the participating ICUs relative to the national intensive care capacity.

Results: The participating ICUs had 442 beds available for admissions, which was estimated to be 42% of the national ICU capacity. At the time of the survey, 455 patients were currently admitted and 151 were included in the analysis; 134 (29.5%) patients met criteria for severe sepsis. The most common failing organ system was the respiratory system (90%), and most patients were admitted following surgery (37%) and were admitted because of acute infection (62%). The most prevalent source of infection was the lung (47%). The estimated duration of ICU stay for severe sepsis patients was 13.3 +/- 1.1 days.

Conclusion: The annual number of admissions for severe sepsis in Dutch ICUs was calculated at 8643 +/- 929 cases/year, which is 0.054% of the population, 0.61% of hospital admissions and 11% of ICU admissions.

Citing Articles

Early sepsis recognition: a pilot study using a rapid high-multiplex host-response mRNA diagnostic test.

Lu J, Ter Voert M, Unal M, Whitfield N, Liesenfeld O, Ter Maaten J Intensive Care Med Exp. 2025; 13(1):21.

PMID: 39982589 PMC: 11845329. DOI: 10.1186/s40635-025-00735-x.


Transformer-based model for predicting length of stay in intensive care unit in sepsis patients.

Kim J, Kim G, Kim J, Kim K, Maeng J, Shin Y Front Med (Lausanne). 2025; 11():1473533.

PMID: 39845825 PMC: 11752922. DOI: 10.3389/fmed.2024.1473533.


Societal costs of sepsis in the Netherlands.

Luijks E, van der Slikke E, van Zanten A, Ter Maaten J, Postma M, Hilderink H Crit Care. 2024; 28(1):29.

PMID: 38254226 PMC: 10802003. DOI: 10.1186/s13054-024-04816-3.


Prevalence and Outcome of Sepsis: Mortality and Prolonged Intensive Care Unit Stay among Sepsis Patients Admitted to a Tertiary Centre in Malaysia.

Kari K, Wan Muhd Shukeri W, Yaacob N, Li A, Zaini R, Mazlan M Malays J Med Sci. 2024; 30(6):120-132.

PMID: 38239259 PMC: 10793138. DOI: 10.21315/mjms2023.30.6.12.


Emergency, ABO-Incompatible Living Donor Liver Re-Transplantation for Graft Failure Complicated by Pneumonia-Associated Sepsis.

Kim S, Kim Y J Clin Med. 2023; 12(3).

PMID: 36769757 PMC: 9917672. DOI: 10.3390/jcm12031110.


References
1.
Bernard G, Vincent J, Laterre P, LaRosa S, Dhainaut J, Lopez-Rodriguez A . Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001; 344(10):699-709. DOI: 10.1056/NEJM200103083441001. View

2.
Freeman J, HUTCHISON G . Prevalence, incidence and duration. Am J Epidemiol. 1980; 112(5):707-23. DOI: 10.1093/oxfordjournals.aje.a113043. View

3.
Angus D, Wax R . Epidemiology of sepsis: an update. Crit Care Med. 2001; 29(7 Suppl):S109-16. DOI: 10.1097/00003246-200107001-00035. View

4.
Verbrugh H, Broers D . [Bacteremia in 2 general hospitals: the tip of the iceberg of hospital infections]. Ned Tijdschr Geneeskd. 1986; 130(10):441-5. View

5.
. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992; 20(6):864-74. View